FT

Thermo Fisher’s €10.7bn takeover of Qiagen collapses after investor revolt

Failure marks a rare example of a deal faltering because Covid-19 improved target’s performance

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button